0 Yorumlar
0 hisse senetleri
168 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Microbiome-Based Therapeutics Market Forecast: Industry Size, Share, and Future Trends"Global Executive Summary Microbiome-Based Therapeutics Market: Size, Share, and Forecast The global Microbiome-Based Therapeutics market size was valued at USD 3.17 billion in 2024 and is expected to reach USD 18.29 billion by 2032, at a CAGR of 24.50% during the forecast period This Microbiome-Based Therapeutics Market research report contains specific...0 Yorumlar 0 hisse senetleri 172 Views 0 önizleme
-
Nucleic Acid-Based Therapeutics Market Outlook: Growth Trends & Market Opportunities"Executive Summary Nucleic Acid-Based Therapeutics Market Size and Share Analysis Report The global nucleic acid-based therapeutics market size was valued at USD 4.94 billion in 2024 and is expected to reach USD 14.38 billion by 2032, at a CAGR of 14.29% during the forecast period This Nucleic Acid-Based Therapeutics Market report is useful in evaluating...0 Yorumlar 0 hisse senetleri 162 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction Adult malignant gliomas are among the most aggressive and lethal cancers of the central nervous system. Originating in the glial cells of the brain, these tumors are characterized by rapid progression, high recurrence rates, and limited long-term survival outcomes. The most common and severe type, glioblastoma multiforme (GBM), remains extremely challenging to treat, despite...0 Yorumlar 0 hisse senetleri 813 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Growth Drivers: Share, Value, Size, and Insights"Executive Summary Adult Malignant Glioma Therapeutics Market Research: Share and Size Intelligence Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report makes available the...0 Yorumlar 0 hisse senetleri 750 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Industry Statistics: Growth, Share, Value, Insights, and Trends"Market Trends Shaping Executive Summary Adult Malignant Glioma Therapeutics Market Size and Share Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market report performs geographical...0 Yorumlar 0 hisse senetleri 532 Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market Scope: Growth, Share, Value, Size, and Trends"Executive Summary Adult Malignant Glioma Therapeutics Market Market Size and Share Across Top Segments CAGR Value Global adult malignant glioma therapeutics market size was valued at USD 2.63 billion in 2024 and is projected to reach USD 5.43 billion by 2032, with a CAGR of 9.50% during the forecast period of 2025 to 2032. Adult Malignant Glioma Therapeutics Market Market report has...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Adult Malignant Glioma Therapeutics Market: Comprehensive Analysis and Future OutlookIntroduction Adult malignant glioma represents one of the most aggressive and lethal forms of primary brain tumors, posing a significant clinical and economic burden worldwide. Characterized by rapid progression, invasive growth, and limited responsiveness to conventional therapies, malignant gliomas—particularly glioblastoma—continue to challenge oncologists and neuroscientists...0 Yorumlar 0 hisse senetleri 619 Views 0 önizleme
-
Anti-Tuberculosis Therapeutics Market Size, Trends, Growth and Forecast 2025-2033Market OverviewThe global anti-tuberculosis therapeutics market size reached USD 1,530.1 Million in 2024. Forecasts indicate expansion to USD 2,552.2 Million by 2033, reflecting a CAGR of 5.56% during 2025-2033. This growth is driven by increasing healthcare expenditure, favorable reimbursement policies, technological progress, and expanding public-private partnerships. Anti-tuberculosis...0 Yorumlar 0 hisse senetleri 700 Views 0 önizleme
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Comprehensive Outlook on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the...0 Yorumlar 0 hisse senetleri 688 Views 0 önizleme
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market: Growth Trends and Share Breakdown The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Yorumlar 0 hisse senetleri 436 Views 0 önizleme
-
Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Share and Growth Forecast Across Major RegionsMarket Trends Shaping Executive Summary Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Size and Share CAGR Value Data Bridge Market Research analyses that the Asia-Pacific prescription digital therapeutics (PDTx) market was valued at USD 96.38 million in 2021 and is expected to reach USD 545.70 million by 2029, registering a CAGR of 24.2% during the forecast period of...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Are Innovative Heart Failure Drugs Changing the Outlook for Cardiovascular Care?Executive Summary Heart Failure Drugs Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. This Heart Failure Drugs Market Research Report also conducts analysis...0 Yorumlar 0 hisse senetleri 275 Views 0 önizleme
-
Are Prescription Drugs Driving the Next Era of Global Healthcare Innovation?Key Drivers Impacting Executive Summary Prescription Drugs Market Size and Share CAGR Value The global prescription drugs market size was valued at USD 1,230.28 billion in 2024 and is expected to reach USD 2,451.41 billion by 2032, at a CAGR of 9.00% during the forecast period The large-scale Prescription Drugs Market report presents the best...0 Yorumlar 0 hisse senetleri 274 Views 0 önizleme
Arama Sonuçları
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek